Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$98.91
-4.0%
$109.10
$77.56
$116.04
$24.06B0.712.03 million shs3.45 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$149.27
-0.4%
$154.19
$143.13
$175.97
$359.24B0.558.67 million shs6.53 million shs
McKesson Co. stock logo
MCK
McKesson
$528.86
-0.3%
$530.38
$352.34
$544.81
$69.50B0.45626,262 shs866,981 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.01%-4.17%-10.18%-4.40%+21.15%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.00%+2.14%-2.11%-4.69%-8.35%
McKesson Co. stock logo
MCK
McKesson
+0.00%-2.66%-1.15%+4.84%+49.22%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.667 of 5 stars
2.34.03.33.62.51.72.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9054 of 5 stars
3.23.04.23.93.02.51.9
McKesson Co. stock logo
MCK
McKesson
4.7652 of 5 stars
2.45.03.33.01.92.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.50
Moderate Buy$105.796.95% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8617.81% Upside
McKesson Co. stock logo
MCK
McKesson
2.83
Moderate Buy$536.711.49% Upside

Current Analyst Ratings

Latest JNJ, MCK, and CAH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/3/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$110.00 ➝ $115.00
5/3/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$134.00 ➝ $128.00
4/30/2024
McKesson Co. stock logo
MCK
McKesson
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$575.00 ➝ $620.00
4/29/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$96.00 ➝ $94.00
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/15/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
4/15/2024
McKesson Co. stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$522.00 ➝ $548.00
4/10/2024
McKesson Co. stock logo
MCK
McKesson
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$510.00 ➝ $570.00
(Data available from 5/5/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$205.01B0.12$8.68 per share11.39($13.41) per share-7.38
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.22$13.67 per share10.92$29.09 per share5.13
McKesson Co. stock logo
MCK
McKesson
$276.71B0.25$32.23 per share16.41($10.99) per share-48.12

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$261M$2.2543.9613.050.990.25%-54.74%3.98%8/20/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.3113.662.4645.26%36.70%15.07%7/18/2024 (Estimated)
McKesson Co. stock logo
MCK
McKesson
$3.56B$22.0723.9617.031.410.99%-262.63%5.96%5/7/2024 (Confirmed)

Latest JNJ, MCK, and CAH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
McKesson Co. stock logo
MCK
McKesson
$6.39N/A-$6.39N/AN/AN/A  
5/2/2024Q3 2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.95$2.08+$0.13$3.11$56.05 billion$54.90 billion      
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
2/7/2024Q3 2024
McKesson Co. stock logo
MCK
McKesson
$7.05$7.74+$0.69$11.06$77.93 billion$80.90 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.002.02%+1.00%88.89%27 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.19%+5.70%29.68%63 Years
McKesson Co. stock logo
MCK
McKesson
$2.480.47%+11.80%11.24%16 Years

Latest JNJ, MCK, and CAH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.47%5/31/20246/3/20247/1/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
2/6/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50061.92%3/28/20244/1/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.98
0.50
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.36
1.17
0.91
McKesson Co. stock logo
MCK
McKesson
N/A
0.92
0.50

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
McKesson Co. stock logo
MCK
McKesson
85.07%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.15%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
McKesson Co. stock logo
MCK
McKesson
0.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,000243.23 million242.87 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.40 billionOptionable
McKesson Co. stock logo
MCK
McKesson
51,000131.41 million131.13 millionOptionable

JNJ, MCK, and CAH Headlines

SourceHeadline
LSV Asset Management Has $377.22 Million Stock Position in McKesson Co. (NYSE:MCK)LSV Asset Management Has $377.22 Million Stock Position in McKesson Co. (NYSE:MCK)
marketbeat.com - May 5 at 10:47 AM
River Global Investors LLP Sells 6,055 Shares of McKesson Co. (NYSE:MCK)River Global Investors LLP Sells 6,055 Shares of McKesson Co. (NYSE:MCK)
marketbeat.com - May 4 at 6:37 PM
McKesson (NYSE:MCK) Raised to Strong-Buy at StockNews.comMcKesson (NYSE:MCK) Raised to Strong-Buy at StockNews.com
americanbankingnews.com - May 4 at 2:44 AM
Amalgamated Bank Has $16.36 Million Holdings in McKesson Co. (NYSE:MCK)Amalgamated Bank Has $16.36 Million Holdings in McKesson Co. (NYSE:MCK)
marketbeat.com - May 3 at 11:38 PM
Heres How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth TodayHere's How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth Today
benzinga.com - May 3 at 10:44 PM
Slavery at Fort Defiance: App State students and faculty present findingsSlavery at Fort Defiance: App State students and faculty present findings
yahoo.com - May 2 at 9:54 PM
Raymond James Financial Services Advisors Inc. Increases Stock Position in McKesson Co. (NYSE:MCK)Raymond James Financial Services Advisors Inc. Increases Stock Position in McKesson Co. (NYSE:MCK)
marketbeat.com - May 2 at 8:45 PM
Unveiling 4 Analyst Insights On CencoraUnveiling 4 Analyst Insights On Cencora
markets.businessinsider.com - May 2 at 1:40 PM
Medline to buy Ecolab’s surgical product unit for nearly $1 billionMedline to buy Ecolab’s surgical product unit for nearly $1 billion
chicagobusiness.com - May 2 at 1:40 PM
Seeking Clues to McKesson (MCK) Q4 Earnings? A Peek Into Wall Street Projections for Key MetricsSeeking Clues to McKesson (MCK) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
zacks.com - May 2 at 10:21 AM
Cardinal Health Stock (NYSE:CAH): Dip Creates Long-Term OpportunityCardinal Health Stock (NYSE:CAH): Dip Creates Long-Term Opportunity
msn.com - May 1 at 1:13 PM
Van ECK Associates Corp Decreases Stake in McKesson Co. (NYSE:MCK)Van ECK Associates Corp Decreases Stake in McKesson Co. (NYSE:MCK)
marketbeat.com - May 1 at 7:20 AM
McKesson (NYSE:MCK) Price Target Raised to $620.00 at CitigroupMcKesson (NYSE:MCK) Price Target Raised to $620.00 at Citigroup
americanbankingnews.com - May 1 at 4:26 AM
OPINION | Don’t Panic About Your Right to Protest: How the Recent SCOTUS Decision Affects Us in WashingtonOPINION | Don’t Panic About Your Right to Protest: How the Recent SCOTUS Decision Affects Us in Washington
southseattleemerald.com - April 30 at 10:10 PM
Is it illegal to protest in Texas? Fact-checking false claimsIs it illegal to protest in Texas? Fact-checking false claims
msn.com - April 30 at 10:10 PM
Sivik Global Healthcare LLC Decreases Holdings in McKesson Co. (NYSE:MCK)Sivik Global Healthcare LLC Decreases Holdings in McKesson Co. (NYSE:MCK)
marketbeat.com - April 30 at 9:12 PM
McKesson (NYSE:MCK) Given New $620.00 Price Target at CitigroupMcKesson (NYSE:MCK) Given New $620.00 Price Target at Citigroup
marketbeat.com - April 30 at 11:19 AM
Earnings Preview: McKesson (MCK) Q4 Earnings Expected to DeclineEarnings Preview: McKesson (MCK) Q4 Earnings Expected to Decline
zacks.com - April 30 at 11:06 AM
Sherrod Brown says Big Pharma is price gouging — the industry has given him $1.4 millionSherrod Brown says Big Pharma is price gouging — the industry has given him $1.4 million
msn.com - April 30 at 7:09 AM
McKesson: Time To Get More CautiousMcKesson: Time To Get More Cautious
seekingalpha.com - April 30 at 7:09 AM
Nuvalence acquired by accounting and consulting giantNuvalence acquired by accounting and consulting giant
bizjournals.com - April 30 at 2:08 AM
McKesson (MCK) to Release Quarterly Earnings on TuesdayMcKesson (MCK) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - April 30 at 1:26 AM
McKesson Co. (NYSE:MCK) Stake Decreased by Anchor Capital Advisors LLCMcKesson Co. (NYSE:MCK) Stake Decreased by Anchor Capital Advisors LLC
marketbeat.com - April 29 at 5:17 PM
Court ruling on protest liability wont stop collective actionCourt ruling on protest liability won't stop collective action
msn.com - April 29 at 4:07 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cardinal Health logo

Cardinal Health

NYSE:CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
McKesson logo

McKesson

NYSE:MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.